Literature DB >> 2373851

Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel.

A C Reboli1, J F John, C G Platt, J R Cantey.   

Abstract

The reported prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) by hospital personnel averages 2.5%. From August 1985 to September 1987, 155 patients at our Veterans' Affairs Medical Center (VAMC) were colonized or infected with MRSA. In December 1986, only two (2.1%) of 94 healthcare workers were identified as nasal carriers. Prompted by a sharp increase in the number of patients with MRSA in early 1987, contact tracing identified 450 employees, of whom 36 (8%) were nasal carriers. Thirty-five percent of surgical residents (7 of 20) were nasal carriers. Prior to being identified as a nasal carrier, one surgical resident was associated with the inter-hospital spread of the VAMC MRSA strain to the burn unit of the affiliated university hospital. Three family members of two employee carriers were also found to harbor the epidemic strain. All 36 carriers were decolonized with various antimicrobial combinations. Vigorous infection control measures were effective in controlling the epidemic. The frequency of MRSA carriage by hospital personnel at our medical center during the epidemic proved higher than previously appreciated. Thus, healthcare workers may comprise a sizable MRSA reservoir. During an MRSA epidemic, infection control should attempt to identify and decolonize this hospital reservoir, as these individuals can disseminate MRSA both within the hospital as well as into the community.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373851     DOI: 10.1086/646174

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  8 in total

1.  Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.

Authors:  Benjamin Dangerfield; Andrew Chung; Brandon Webb; Maria Teresa Seville
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

Review 2.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

3.  Phenotypical and genotypical characterization of epidemic clumping factor-negative, oxacillin-resistant Staphylococcus aureus.

Authors:  A Schwarzkopf; H Karch; H Schmidt; W Lenz; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

4.  Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene.

Authors:  W Witte; C Braulke; D Heuck; C Cuny
Journal:  Infection       Date:  1994       Impact factor: 3.553

5.  Nasal carriage of enterotoxin-producing Staphylococcus aureus among restaurant workers in Kuwait City.

Authors:  M A al Bustan; E E Udo; T D Chugh
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

6.  Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature.

Authors:  M A Gardam
Journal:  Can J Infect Dis       Date:  2000-07

7.  Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin.

Authors:  R Darouiche; C Wright; R Hamill; M Koza; D Lewis; J Markowski
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

8.  The extent of environmental and body contamination through aerosols by hydro-surgical debridement in the lumbar spine.

Authors:  David Putzer; Ricarda Lechner; Debora Coraca-Huber; Astrid Mayr; Michael Nogler; Martin Thaler
Journal:  Arch Orthop Trauma Surg       Date:  2017-03-20       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.